Glukagonoma: Olgu sunumu
Glukagonoma sendromu, nekrotik migratuar eritem, diabetes mellitus, kilo kaybı, anemi, stomatit, tromboembolizm, gastrointestinal- nöropsikiyatrik bozukluklarla karekterize, pankreasın alfa hücrelerinden kaynaklanan paraneoplastik bir fenomendir. Bu yazıda glukagonomalı bir olgu sunulurken sendromla ilgili literatür de gözden geçirilmiştir.
Glucagonoma: A case report
Glucagonoma syndrome is a paraneoplastic phenomenon characterized by alpha cell pancreatic tumor; necrolytic migratory erythema, diabetes, weight loss, anemia, stomatitis, thromboembolism and gastrointestinal-neuropsychiatric disturbances. We presented a case of glucagonoma and rewieved the literature on this syndrome.
___
- 1. Wilson JD, Fasten DW, Textbook of Williams Endocrinology.Fifth Edition, W.B.Saunders Company, Philadelphia. 1992, 32:1569.
- 2. Greenspen FS, Godre RG. Basic Clinical Endocrinology. Sixth Edition. Me Graw Hill.New York. 1992;17; 617.
- 3. Sweet RD. Dermatosis specifically associated with a tumor of pancreatic alpha cells. Br J Dermatol ,1974;90:301-8.
- 4. Wilkinson AS. Necrolytic migratory erytema with carcinoma of the pancreas. Trans St John's Hose Dermatol So 1973;59:244-50.
- 5. Bloom SR, Polak JM. Glucagonoma Syndrome, Am J Med. 1987; 82:25-36.
- 6. Binnick AN, Spencer SK, Dennison WL, et al: Glucagonoma Syndrome, Report of two cases and literature review. Arch Dermatol 1997;113:749-54.
- 7. Stacpoole PW. The glucagonoma syndrome clinical features, diagnosis and treatment. Endocrinol Rew, 1997; 2:347-61.
- 8: Mallinson CN, Bloom SR, Warin AP. A glucagonoma syndrome. Lancet 1974; 2:1-5.
- 9: Wood SM, Polak JM, Bloom SR.GIucagonoma syndrome In: Lefebure PJ ed. Handbook of Experimental Pharmacology. Vol 66 part:2. Glucagon. Stuttgard. Springer-Verlag, 1983; 411-30.
- 10. Higgins GA, Recont L, Fiscman AB. The glucagonoma syndrome: surgically curable diabetes. Am J Surg 1979; 137:142-148
- 11. Almdal TP, Heindorff H, Bordram L et al: Increased amino acid clearence and urea synthesis in a patient with glucagonoma. Gut 1990; 31:946-48.
- 12. Chastain MA. The glucagonoma syndrome : a review of its features and discussion perspectives. Am J Med Sci 2001; 21(5);396-20.
- 13: Hicks T, Tumberg LA. lanfluence of glucagon on the human jejunum. Gastroenterology 1974; 67:1114-18.
- 14. Santargelo WC, Unger RH, Orci L et al. Somatostatin analoque- induced remission of necrolytic migratory eryhemo without changes in plasma glucagon concentrantations. Pancreas 1986; 1:464-69.
- 15. Nishiguchi S, Shiami S, İshuzu H. A case of glucagonoma with high uptake on F-18 fluorodeoxyglucose PET. Ann Nucl Med 2001; 15 (3): 259-62.
- 16. Brentjens R, Soltz L. Islet cell tumors of the pancreas the medical oncologist's perspectives. Surg Clin North Am 2001 ;81 (3); 527-42.